Fig. 2: OS and PFS by mutation status.
From: Multigene germline and somatic testing for epithelial ovarian cancer in China
Five-year Kaplan‒Meier curve for OS and PFS in EOC patients stratified by A, D germline + somatic mutation carriers of HR genes under LP+ strategy, B, E germline + somatic mutation carriers of HR genes under VUS+ strategy, and C, F germline + somatic mutation carriers of BRCA1/2 genes under VUS+ strategy. The p values were calculated with the log-rank test. WT wild-type (including no variants, benign and likely benign variants), LP+ likely pathogenic and pathogenic variants. VUS+, LP+, and VUS variants. Tier II+, class I and II somatic variants, Tier III+, class I, II, and III somatic variants.
